Eli Lilly and Co at Barclays Global Healthcare Conference Transcript
All right. Good morning, and welcome to the second day of the Barclays Global Health Care Conference. My name's Geoff Meacham. I'm the Biopharma Analyst here. I've Olivia Brayer from my team on stage with me as well.
And it's our the pleasure to have Eli Lilly up here on stage for a fireside chat. And we have Chief Scientific Officer Dan Skovronsky. Dan, welcome.
Yes. Good morning, Geoff. Thanks for having us here.
Questions & Answers
Yes. So the conversations typically on Lilly, I wanted to ask you, it's -- tend to focus on diabetes, and that's probably the most topical. So I guess the first question is, give us a sense for the successes that Trulicity has had commercially. And then maybe what is your kind of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
